Large-scale testing (Phase 3)Study completedNCT01863186
What this trial is testing
Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
Who this might be right for
Opioid DependenceAcute Opioid Withdrawal Syndrome
USWM, LLC (dba US WorldMeds) 603